TABLE 1

Plasma pharmacokinetic parameters of 125I-Aβ40 in WT and APP,PS1 mice Data are mean ± S.D.


Parameter

8 Weeks

24 Weeks

p a
WT
APP,PS1
p
WT
APP,PS1
p
Cmax (μCi/ml) 18.9 ± 2.0 10.5 ± 2.1 ** 17.4 ± 2.7 14.7 ± 4.1 N.S. N.S.
t1/2 (α) (min) 0.8 ± 0.1 0.9 ± 0.4 N.S. 0.9 ± 0.1 1.1 ± 0.3 N.S. N.S.
t1/2 (β) (min) 11.9 ± 5.1 9.4 ± 6.1 N.S. 9.2 ± 2.3 15.0 ± 11.3 N.S. N.S.
Clearance (ml/min/g) 0.09 ± 0.02 0.15 ± 0.02 * 0.09 ± 0.02 0.09 ± 0.02 N.S. *
VSS (ml/g) 1.0 ± 0.3 1.4 ± 0.7 N.S. 0.9 ± 0.17 1.2 ± 0.76 N.S. N.S.
AUC (min × μCi/ml)
53.0 ± 11.6
35.0 ± 4.5
*
50.5 ± 7.3
52.1 ± 9.6
N.S.
*
  • N.S., nonsignificant, p > 0.05. Statistical significance was indicated by *p < 0.05 and **p < 0.01 using Student's t test.

  • a Comparison between 8- and 24-week-old APP,PS1 mice